Pharmaceutical Outsourcing covers news of importance to the contract services segment of the pharmaceutical industry.
Collected from the most trusted on-line resources, these news stories are chosen and published here based on their relevance to the pharmaceutical industry.
Topics of interest typically include: mergers and acquisitions, service additions, new capabilities, personnel changes, news from the FDA and other international regulatory and standard-setting agencies, and new outsourcing contracts and deals.
If you are looking to stay up-to-date with the news in your industry, this resource is vital for your industry knowledge.
Tuesday, January 10, 2023
Sterling Pharma Solutions announced the completion of its acquisition of an active pharmaceutical ingredient (API) manufacturing facility in Ringaskiddy, Ireland, from Novartis, in a deal that was initially announced in March 2022.
read more
Tuesday, January 10, 2023
Avantor, Inc. has entered into a multi-year supply and services agreement with Catalent, Inc. enabling the development and supply of better treatments for patients worldwide.
read more
Tuesday, January 10, 2023
Novotech an Asia Pacific centered biotech CRO announced the acquisition of CBR International, a global product development, clinical oversight and strategic regulatory operations group.
read more
Tuesday, January 10, 2023
Ajinomoto Co., Inc. announced a license agreement with Exelixis, Inc. to incorporate AJICAP®, Ajinomoto Co.’s proprietary site-specific bioconjugation and linker technologies, in the development of certain of Exelixis’ antibody-drug conjugate (ADC) ...
read more
Tuesday, January 10, 2023
Sirio Pharma Co., Ltd. has completed the acquisition of a majority stake in Best Formulations LLC, a contract manufacturer of Nutritional Supplements and Personal Care products based in California.
read more
Tuesday, January 10, 2023
Qosina, a global supplier of OEM single- use components to the medical and pharmaceutical industries, is pleased to announce a partnership with ILC Dover, a leader in the innovative design and production of solutions for biopharmaceutical, ...
read more
Tuesday, January 10, 2023
Premier Research and Centogene N.V. have announced a strategic partnership to provide end-to-end support in rare disease clinical trials. The collaboration aims to improve patient identification, stratification, recruitment, and enrollment, thereby ...
read more
Tuesday, January 10, 2023
Qosina, a global supplier of OEM single-use components to the medical and biopharmaceutical industries, is pleased to introduce an Irradiate to Order service for its single-use bioprocess component portfolio.
read more
Agilent Technologies Inc. announced it is investing approximately $725 million to double manufacturing capacity of therapeutic nucleic acids in response to rapid growth of the $1 billion market and strong demand for the company’s high-quality active ...
read more
GNS announced its rebranding as Aitia (pronounced "ay-tee-ah"). Aitia, derived from the Greek word for causality, will focus on further leveraging its Gemini Digital Twins to discover the next generation of breakthrough drugs to improve outcomes for ...
read more
Huma Therapeutics Limited has acquired Alcedis GmbH. Through the acquisition, Huma will form an advanced clinical trials division offering digital solutions across the entire development pipeline, from early stage through to Phase IV hybrid and fully...
read more
PhoreMost Ltd., has triggered a milestone payment in its multi-project target discovery collaboration with Boehringer Ingelheim. This was achieved by identifying and validating novel targets supporting Boehringer Ingelheim’s ambition to develop first...
read more
Paratek Pharmaceuticals, Inc. announced the receipt of a $36.4 million milestone payment associated with the second procurement of NUZYRA® (omadacycline) under the company’s Project BioShield contract with the Biomedical Advanced Research and ...
read more
X-Chem announced the establishment of a research partnership with Sironax, in which X-Chem will leverage its powerful DEL platform to support Sironax’s drug discovery pipeline.
read more
Ginkgo Bioworks announced the opening of Bioworks7, the latest expansion of its biological engineering foundry. With this new space, Ginkgo increases its capacity and capabilities to serve its partners in the spaces of cell and gene therapy, ...
read more